Read about the first Heart Education Journal Club, where Dr Iacopo Olivotto, lead clinical investigator of the EXPLORER-HCM trial, and Dr Martin Maron, session Chair, discussed the effects mavacamten on exercise capability and functional class in patients with obstructive hypertrophic cardiomyopathy (HCM).
The report breaks down what was discussed during the live journal club and the complexity and hyperdynamic consequences of HCM as well the mode of action of mavacamten and the EXPLORER-HCM study.
